These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17390482)

  • 1. Anti-HIV agents. Promising results from a saquinavir study.
    TreatmentUpdate; 2007 Jan; 19(1):9-10. PubMed ID: 17390482
    [No Abstract]   [Full Text] [Related]  

  • 2. Saquinavir plus ritonavir reduce viral load by 99.9 percent.
    Vazquez E
    Posit Aware; 1996; 7(6):8-9. PubMed ID: 11363983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of saquinavir/ritonavir 1000/100 mg twice daily in patients with tuberculosis receiving rifampin.
    Losso MH; Lourtau LD; Toibaro JJ; Saenz C; González C
    Antivir Ther; 2004 Dec; 9(6):1031-3. PubMed ID: 15651762
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-HIV agents. Starting therapy with saquinavir.
    TreatmentUpdate; 2007 Jan; 19(1):8-9. PubMed ID: 17393566
    [No Abstract]   [Full Text] [Related]  

  • 5. [Good experiences with saquinavir. Double boosting of protease inhibitors gains significance].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():44. PubMed ID: 15373047
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined protease results continue to hold up.
    McGuire S
    Posit Aware; 1997; 8(1):15. PubMed ID: 11364089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HIV agents. A protease-only regimen--Kaletra and saquinavir.
    TreatmentUpdate; 2004; 16(3):8. PubMed ID: 17216837
    [No Abstract]   [Full Text] [Related]  

  • 8. Saquinavir: major study shows survival benefit in treatment-naive patients.
    James JS
    AIDS Treat News; 1997 Jul; (No 274):6. PubMed ID: 11364463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HIV agents. Atazanavir and saquinavir.
    TreatmentUpdate; 2004; 16(3):9-10. PubMed ID: 17219610
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase.
    TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608
    [No Abstract]   [Full Text] [Related]  

  • 11. Saquinavir (Fortovase or Invirase).
    Res Initiat Treat Action; 2000 Mar; 6(1):24-5. PubMed ID: 11708182
    [No Abstract]   [Full Text] [Related]  

  • 12. Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks.
    Kosalaraksa P; Bunupuradah T; Engchanil C; Boonrak P; Intasan J; Lumbiganon P; Burger D; Ruxrungtham K; Schutz M; Ananworanich J;
    Pediatr Infect Dis J; 2008 Jul; 27(7):623-8. PubMed ID: 18520443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Searching for the right dose of ritonavir-saquinavir.
    TreatmentUpdate; 2001 Sep; 13(5):3. PubMed ID: 11768860
    [No Abstract]   [Full Text] [Related]  

  • 14. Data in from first head-to-head protease inhibitor.
    AIDS Patient Care STDS; 1998 Apr; 12(4):317. PubMed ID: 11361961
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir.
    Ananworanich J; Gayet-Ageron A; Ruxrungtham K; Chetchotisakd P; Prasithsirikul W; Kiertiburanakul S; Munsakul W; Raksakulkarn P; Tansuphasawadikul S; LeBraz M; Jupimai T; Ubolyam S; Schutz M; Hirschel B;
    Antivir Ther; 2008; 13(3):375-80. PubMed ID: 18572750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soft gel saquinavir has high exposure.
    AIDS Alert; 1997 Dec; 12(12):143-4. PubMed ID: 11364835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New formulation of saquinavir (Fortovase) is more effective.
    Tam CW
    Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease.
    Merry C; Mulcahy F; Barry M; Gibbons S; Back D
    AIDS; 1997 Feb; 11(2):268-9. PubMed ID: 9030388
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HIV agents. Saquinavir with fosamprenavir.
    TreatmentUpdate; 2004; 16(3):9. PubMed ID: 17219609
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-HIV agents. Atazanavir as a booster for protease inhibitors.
    TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.